Veterinary Medicines

Noroclox DC Xtra Intramammary Suspension

Authorised
  • Cloxacillin hemibenzathine
Download as PDF

Product identification

Medicine name:
Noroclox DC Xtra Intramammary Suspension
Active substance:
  • Cloxacillin hemibenzathine
Target species:
  • Cattle
Route of administration:
  • Intramammary use

Product details

Active substance and strength:
  • Cloxacillin hemibenzathine
    1530.76
    milligram(s)
    /
    1.00
    Syringe
Pharmaceutical form:
  • Intramammary suspension
Withdrawal period by route of administration:
  • Intramammary use
    • Cattle
      • Meat and offal
        28
        day
      • Milk
        96
        hour
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ51CF02
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Ireland
Available in:
  • Ireland
Package description:
  • Noroclox DC Xtra will be supplied in cartons of 24 syringes. Each 5.4g syringe containing 600mg Cloxacillin.
  • Noroclox DC Xtra will be supplied in cartons of 120 syringes. Each 5.4g syringe containing 600mg Cloxacillin.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Informed consent (abridged application) - Council Directive 81/851/EEC
Marketing authorisation holder:
  • Norbrook Laboratories (Ireland) Limited
Marketing authorisation date:
Manufacturing sites for batch release:
  • Norbrook Laboratories Limited
  • Norbrook Manufacturing Limited
Responsible authority:
  • Health Products Regulatory Authority
Authorisation number:
  • VPA22664/043/001
Date of authorisation status change:

Documents

Summary of Product Characteristics

English (PDF)
Published on: 3/05/2024
Download